Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ANTIVIRAL TECHNOLOGIES, INC. | Financial_Report.xls |
| 10-K - ANTIVIRAL TECHNOLOGIES, INC. | f10k2012finalclean3262013.htm |
| EX-32 - ANTIVIRAL TECHNOLOGIES, INC. | exhibit322.htm |
| EX-32 - ANTIVIRAL TECHNOLOGIES, INC. | exhibit321.htm |
| EX-31 - ANTIVIRAL TECHNOLOGIES, INC. | exhibit312.htm |
| EX-31 - ANTIVIRAL TECHNOLOGIES, INC. | exhibit311.htm |
1
OMEGA BIO-PHARMA STATUS REPORT
2
OMEGA BIO-PHARMA STATUS REPORT
OBI-104C5XC1 MY | Malaysia | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound | PI20064570 | (Liang, Chi, Xu, Chan) | 11/27/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | MY-141003-A | 2/12/2010 |
OBI-104C5XC1 PK | Pakistan | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections | 1530/2006 | (Liang, Chi, Xu, Chan) | 11/18/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 TH | Thailand | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections | 0601005885 | (Liang, Chi, Xu, Chan) | 11/27/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 TW | Taiwan | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections | 095143633 | (Liang, Chi, Xu, Chan) | 11/24/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 AP | ARIPO (African Regional Industrial Property Organization) | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | AP/P/2008/004511 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 AU | Australia | Obio Pharmaceutical (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 2006318355 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | 2006318355 | 4/26/2012 |
OBI-104C5XC1 BR | Brazil | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | PI0619377-3 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 CA | Canada | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 2,631,241 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 CN | China | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 200680044305.6 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | ZL200680044305.6 | 01/26/2011 |
OBI-104C5XC1 EPO | Europe (extended to 18 European countries) | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 06838553.3 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | 1954258 | 9/5/2012 |
OBI-104C5XC1 IN | India | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 4368/DELNP/2008 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
3
OMEGA BIO-PHARMA STATUS REPORT
OBI-104C5XC1 ID | Indonesia | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | W00200801613 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | ID P0030342 | 3/6/2012 |
OBI-104C5XC1 IL | Israel | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 191705 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 JP | Japan | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 2008-542483 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | 5,138,603 | 11/22/2012 |
OBI-104C5XC1 KR | South Korea | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 10-2008-7015869 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 MX | Mexico | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | MX/A/2008/006851 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | 297893 | 4/4/2012 |
OBI-104C5XC1 NZ | New Zealand | Obio Pharmaceutical (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 568464 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | 568464 | 01/08/2011 |
OBI-104C5XC1 OA | OAPI (African Intellectual Property Organization) | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 1200800196 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | 14186 | 12/30/2008 |
OBI-104C5XC1 PH | Philippines | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 1-2008-501113 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 RU | Russian Federation | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 2008126272 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | 2431476 | 10/20/2011 |
OBI-104C5XC1 ZA | South Africa | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 2008/05191 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | 2008/05191 | 8/26/2009 |
OBI-104C5XC1 SG | Singapore | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 200803923-2 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
4
OMEGA BIO-PHARMA STATUS REPORT
OBI-104C5XCDIV SG | Singapore | Obio Pharmaceutical (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (as amended) | 201008769-0 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 AE | United Arab Emirates | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 523/2008 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | --- | --- |
OBI-104C5XC1 HK | Hong Kong | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Viral Infections with a Cysteamine Compound (As amended by the PCT) | 09103170.7 | (Liang, Chi, Xu, Chan) | 11/28/2006 | Cysteamine Compositions, and their use, for treating viruses, including Influenza Virus. | HK1123726 | 8/26/2011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
OBI-108 Series | |||||||||
Characteristics: Usage of Cysteamine as an Antiviral Drug together with Other Antiviral Drugs including Tamiflu and/or Vaccines. This patent's major purpose is to extend further Protection of OBI-104, Particularly on Influenza Virus | |||||||||
Docket No. | Country | Assignee | Title | Serial No. | Inventors | Date Filed | Brief Description | Patent No. | Date Granted |
OBI-108P | United States Provisional | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Influenza Infections | US60/940,255 | Liang, Chi, Xu, Chan | 5/25/2007 | Combination treatments using cysteamine and other agents for treating of viruses including Influenza Virus. | --- | --- |
OBI-108X PCT | PCT | Omega-BioPharma (HK) Ltd | Materials and Methods for Treating Influenza Infections | PCT/US2008/064860 | Liang, Chi, Xu, Chan | 5/27/2008 | Combination treatments using cysteamine and other agents for treating of viruses including Influenza Virus. | --- | --- |
OBI-108X US | United States | Omega-BioPharma (H.K.) Ltd | Materials and Methods for Treating Influenza Infections | 12/600,264 | Liang, Chi, Xu, Chan | 1/13/2010 | Combination treatments using cysteamine and other agents for treating of viruses including Influenza Virus. | --- | --- |
OBI-108X JP | Japan | Obio Pharmaceutical (H.K.) Ltd | Materials and Methods for Treating Influenza Infections | 2010-509585 | Liang, Chi, Xu, Chan | 5/27/2008 | Combination treatments using cysteamine and other agents for treating of viruses including Influenza Virus. | --- | --- |
| |||||||||
5
OMEGA BIO-PHARMA STATUS REPORT
OBI-111 Series | |||||||||
Characteristics: This is more detailed application usage of Cysteamine to Treat Influenza virus through an Inhalation of Cysteamine directly to the Respiratory Tract, the exact location where the Influenza Virus attacks. Please refer to another inhalation Influenza drug "RELENZA" same principle. This patent, again, is to further enhance and extend the Protection of OBI-104. | |||||||||
Docket No. | Country | Assignee | Title | Serial No. | Inventors | Date Filed | Brief Description | Patent No. | Date Granted |
OBI-111P | United States Provisional | Obio Pharmaceutical (H.K.) Ltd | Materials and Methods for Treating Viral Infections | 61/180,840 | Thoene | 5/23/2009 | Inhalation Antiviral treatments including for the treatment of Influenza virus. | --- | --- |
OBI-111X US | United States | Obio Pharmaceutical (H.K.) Ltd | Materials and Methods for Treating Viral Infections | 13/302,620 | Thoene | 11/22/2011 | Inhalation Antiviral treatments including for the treatment of Influenza virus. | --- | --- |
OBI-111X PCT | WIPO | Obio Pharmaceutical (H.K.) Ltd | Materials and Methods for Treating Viral Infections | PCT/US2010/035785 | Thoene | 5/21/2010 | Inhalation Antiviral treatments including for the treatment of Influenza virus. | --- | --- |